The Importance of Early Phase Trials in Precision Oncology
Publié le
Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents…
Publié le
Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents…
Publié le
IDDI Complimentary Webinar on the need for integration of biomarker and IVD validation in clinical development Drug development in many…
Publié le
The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology….
Publié le
Listen to IDDI Podcast on IDDI Services Vicky Martin, Sr Business Director US , IDDI Learn more on IDDI…
Publié le
Publié le
IDDI in the Media BIOWIN Newsletter Deux projets de R&D dans les starting-blocks (July 2017): “TREATBEST, est un consortium composé…
Publié le
IDDI organized a webinar on the analytical validation of in-vitro diagnostic devices entitled ‘From Biomarkers to In-vitro Companion Diagnostic Device :…
Publié le
IDDI Accelerates Your Statistical Biomarker-IVD Validation IDDI has experience in the identification and statistical biomarker -IVD validation of diagnostic utility, prognostic and/or…
Publié le
We have experience in the challenging statistical issues that characterize the identification and validation of biomarkers for personalized medicine that have diagnostic utility,…
Publié le
Biostatistical Expertise For Developing New Biomarkers And Diagnostic Tests IDDI has a long-term collaboration with a Sponsor to provide biostatistical…